Blog Archives

ASX Announcement TBG Biotechnology Corp. Confirms CE Mark approval of COVID-19 Nucleic Acid and Antibody Rapid Test Kits – Authorised by the Board of Directors Jitto Arulampalam Chairman  TBG Diagnostics Limited (“TDL” or “Company”) is pleased to announce that its wholly owned subsidiary TBG Biotechnology Corp. (“TBG Taiwan”) has received the CE Mark approval for its ExProbeTM SARS-CoV-2 Testing Kit and SARS-CoV-2 IgG / IgM Rapid Test Kit. CE Mark certification indicates that the ExProbeTM SARS-CoV-2 Testing Kit and SARS-CoV-2 IgG / IgM Rapid Test Kit meet the essential health, safety, and environmental protection requirements of the applicable European regulations to allow the sale of the kit throughout the European Economic Area as well as any country that accepts CE-mark, subject to satisfying regulatory requirements and obtaining import permits for individual countries. Both tests are manufactured by TBG Biotechnology Corp. in Taiwan and will be exported from Taiwan subject to ...